Globus Medical completed its acquisition of Nevro, a spinal cord stimulator company, according to an April 3 news release.
The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio.
The deal was first announced in February, and Nevro was valued at $250 million. Nevro employs HFX spinal cord stimulation, which is used in its Senza SCS system. The company also offers minimally invasive treatments for chronic sacroiliac joint pain.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
